Nyxoah S.A. (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
8.00
-0.15 (-1.84%)
Nov 22, 2024, 4:00 PM EST - Market closed
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $312.48 million as of November 22, 2024. Its market cap has increased by 103.77% in one year.
Market Cap
312.48M
Enterprise Value
262.95M
1-Year Change
103.77%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $312.48M, a decrease of -38.26%. That is a compound annual growth rate of -11.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 314.52M | 132.95% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 324.31M |
| Spok Holdings | 323.55M |
| AC Immune | 320.57M |
| COMPASS Pathways | 318.84M |
| Jasper Therapeutics | 314.73M |
| Design Therapeutics | 310.28M |
| Cerus | 308.29M |
| Delcath Systems | 307.91M |